Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation

Author(s):
Trento, C.; Bernardo, M.E.; Nagler, A.; Kuci, S.; Bornhauser, M.; Kohl, U.; Strunk, D.; Galleu, A.; Sanchez-Guijo, F.; Gaipa, G.; Introna, M.; Bukauskas, A.; Blanc, K. le; Apperley, J.; Roelofs, H.; Campenhout, A. van; Beguin, Y.; Kuball, J.; Lazzari, L.; Avanzini, M.A.; Fibbe, W.; Chabannon, C.; Bonini, C.; Dazzi, F.
Published
2018
Publication type
Article / Letter to editor
Mesenchymal stromal cellsGraft-versus-host diseaseCellular therapyManufacturingProduct specificationRelease criteria
Date issued
2018-11-30
Language
English
Is part of
Biology of Blood and Marrow Transplantation (2018), Vol. 24, no. 11, p. 2365-2370
hdl
1887/87724
doi
10.1016/j.bbmt.2018.07.015